Manifestations of the 16p11.2 recurrent microdeletion are variable, and treatment should be targeted to the specific findings identified.

Early diagnosis and provision of therapies facilitate the best outcome. Referral to other appropriate medical specialists (sue.g.,a developmental/behavioral pediatrician, pediatric neurologist, and/or medical geneticist) is recommended based on specific symptoms or signs.

Neurodevelopmental disabilities including ASD. Interventions may include speech and language therapy, occupational therapy, and physical therapy. Because of the high incidence of expressive language delays, speech therapy and augmentative and assistive means of communication should be considered early.

Guidelines for management of individuals with ASD are available from the American Academy of Pediatrics [Myers et al 2007] (full text).

Seizures. Choice of antiepileptic medication is guided by patient age, seizure type, EEG and imaging findings, side effect profiles, and response to treatment. No specific antiepileptic medications have been identified to be most effective.

Paroxysmal kinesigenic dyskinesia is responsive to low doses of carbamazepine and phenytoin.

Obesity and overweight. It is important to initiate weight management and nutrition counseling in young children before excessive weight gain begins. Control food intake with normal portion sizes and limitation of food intake between meals. Maintain an active lifestyle. Increased calories are specifically ingested in the absence of hunger and suggest that close supervision of portion size and meal times can be beneficial.

Chiari I malformation or syringomyelia. Brain and spine MRI are indicated for new or progressive symptoms suggestive of a Chiari I malformation or syringomyelia, including sleep apnea, dysarthria, dysphagia, gait disturbance, and scoliosis.
